Swiss Cancer Institute
Clinical trials sponsored by Swiss Cancer Institute, explained in plain language.
-
Heat and immune boost: new combo tackles Hard-to-Treat cancers
Disease control CompletedThis trial tested a two-step treatment for people with advanced solid tumors that no longer respond to standard therapies. First, a laser heats and destroys part of the tumor. Then, a drug called IP-001 is injected directly into the treated area to help the immune system recogniz…
Phase: PHASE1, PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Immunotherapy combo shows promise in advanced lung cancer trial
Disease control CompletedThis study tested whether adding an immunotherapy drug (MEDI4736) to standard chemotherapy before surgery helps people with stage IIIA non-small cell lung cancer. 68 participants received the combination treatment. The goal was to see if this approach improves how long people liv…
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC